Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance

E Santoni-Rugiu, LC Melchior, EM Urbanska… - Cancers, 2019 - mdpi.com
… mechanisms inherent in EGFR or by EGFR-independent … intrinsic EGFR-TKI-resistance and
differences and similarities with acquired resistance and among clinically implemented EGFR

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations

J Wang, B Wang, H Chu, Y Yao - OncoTargets and therapy, 2016 - Taylor & Francis
resistance. Citation3,Citation4 This review focuses on the recently identified molecular
mechanisms of intrinsic resistance to EGFR … therapeutic strategies to overcome this resistance. …

[HTML][HTML] Mechanisms of resistance to EGFR tyrosine kinase inhibitors

L Huang, L Fu - Acta Pharmaceutica Sinica B, 2015 - Elsevier
… Here we review and summarize the known resistant mechanisms to EGFR-TKIs and provide
… Although the polymorphism was sufficient to confer intrinsic TKI resistance in chronic …

[HTML][HTML] Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy

R Bianco, T Troiani, G Tortora… - Endocrine-related …, 2005 - erc.bioscientifica.com
EGFR signaling, EGFR blocking monoclonal antibodies and small molecular weight EGFR
tyrosine … -regulated proliferation and an intrinsic resistance to anticancer drugs. Furthermore, …

Mechanisms of resistance to EGFR tyrosine kinase inhibitors and therapeutic approaches: an update

A Ahsan - Lung Cancer and Personalized Medicine: Current …, 2016 - Springer
… associated with the mutation, suggesting the possibility of intrinsic resistance in these
patients. Initially, steric hindrance of TKIs by the “gatekeeper” T790M mutation has been …

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib

MR Maiello, A D'Alessio, A De Luca… - Breast cancer research …, 2007 - Springer
AKT and MAPK signaling are involved in the resistance of breast cancer cells to the EGFR
tyrosine kinase inhibitor gefitinib. RAS proteins are upstream mediators that transfer …

The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer

SA Kono, ME Marshall, KE Ware, LE Heasley - Drug Resistance Updates, 2009 - Elsevier
… signaling through EGFR-independent receptor tyrosine kinases functions as a mechanism
of intrinsic resistance to EGFR TKIs in NSCLC not bearing EGFR or K-Ras mutations. …

Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - Biochemical Journal, 2008 - portlandpress.com
… upon resistance mutations, we performed EGFR (epidermal-growth-factor receptor) resistance
… with T790M in the same EGFR allele conferred complete resistance to erlotinib, lapatinib …

[HTML][HTML] Mechanisms of resistance to EGFR-targeted drugs: lung cancer

F Morgillo, CM Della Corte, M Fasano, F Ciardiello - ESMO open, 2016 - Elsevier
… factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in … Intrinsic resistance may
also be the consequence of … of patients with sensitising EGFR mutations to EGFR-TKIs treatment…

[HTML][HTML] Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort

S Yano, T Yamada, S Takeuchi, K Tachibana… - Journal of thoracic …, 2011 - Elsevier
… High-level HGF expression, EGFR T790M … resistance, respectively. High-level HGF expression
was detected in 29% of tumors with intrinsic resistance (nonresponders), whereas EGFR